Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

(Image credit: ©De Visu/AdobeStock) A recent study identified a large disconnect between patients with neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME) who are treated with intravitreal injections. The survey results highlighted the significant treatment burden experienced by…

Omer Trivizki, MD, MBA, at the 2025 ASRS meeting Omer Trivizki, MD, MBA, Deputy Chair working in Tel Aviv Medical Center presented, “First time results of VOY-101, a novel, complement-modulating gene therapy for geographic atrophy.” This presentation was given at…

(Image credit: ©Alernon77/AdobeStock) jCyte recently announced the dosing of the first patients enrolled in the JC02-88 study for the evaluation of famzeretcel (jCell; jCyte) for the treatment of retinitis pigmentosa (RP).1 Famzeretcel consists of allogeneic retinal progenitor cells (RPCs) administered…

Educational committee member Oluwatosin U. Smith, MD, highlights the 2025 Ophthalmology Times EyeCon® and Optometry Times EyeCon® conference, a multispecialty meeting for ophthalmologists and optometrists, highlighting program updates, collaborative learning opportunities, and evolving approaches in patient care. To learn more…
A large language model digital patient system enhances ophthalmology history taking skills | npj Digital Medicine Nature Source: Author: | Date: 2025-08-04 07:00:00 Source: Author: | Date: 2025-08-04 07:00:00
Evaluation of a simulation-based ophthalmology education workshop for medical students: a pilot project BMC Medical Education Source: Author: | Date: 2025-01-30 08:00:00 Source: Author: | Date: 2025-01-30 08:00:00
Global track for residents: International education, bidirectional impact Mayo Clinic Source: Author: | Date: 2024-10-30 07:00:00 Source: Author: | Date: 2024-10-30 07:00:00

At the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Boston, Orbis International, together with FundamentalVR, introduced a virtual reality (VR) training tool. This immersive VR solution is especially designed for use in low- and…

Lenz Therapeutics announced positive topline results from its Phase 3 CLARITY study, evaluating two investigational formulations, LNZ100 and LNZ101, aimed at treating presbyopia. The study’s findings showcase the effectiveness and safety of these formulations, particularly highlighting LNZ100 (1.75% aceclidine) for…

The American Society of Cataract and Refractive Surgery (ASCRS) is poised to welcome Vance Thompson, MD, as its new president during the organization’s 2024 annual meeting, which begins this Friday at the Boston Convention and Exhibition Center in Boston. This…